Downregulation of leptin by free fatty acids in rat adipocytes: Effects of triacsin C, palmitate, and 2-bromopalmitate

Metabolism: Clinical and Experimental

Volumn 49, Issue 3, 2000, Pages 326-330

  Shintani, Mitsuyo ^a   Nishimura, Haruo ^a   Yonemitsu, Shin ^a   Masuzaki, Hiroaki ^a   Ogawa, Yoshihiro ^a   Hosoda, Kiminori ^a   Inoue, Gen ^a   Yoshimasa, Yasunao ^a   Nakao, Kazuwa ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 BROMOPALMITIC ACID; FATTY ACID; LIGASE INHIBITOR; LONG CHAIN FATTY ACID COENZYME A LIGASE; PALMITIC ACID;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME INHIBITION; FATTY ACID METABOLISM; MALE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; RAT;

EID: 0034019050     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(00)90154-9     Document Type: Article

References (35)

1. Zhang Y, Proenca R, Maffei M, et al: Positional cloning of the mouse obese gene and its human homologue. Nature 372:425-432, 1994
2. Dagogo JS, Fanelli C, Paramore D, et al: Plasma leptin and insulin relationships in obese and nonobese humans. Diabetes 45:695-698, 1996
3. Boden G, Chen X, Mozzoli M, et al: Effect of fasting on serum leptin in normal human subjects. J Clin Endocrinol Metab 81:3419-3423, 1996
4. DeVos P, Lefebvre AM, Miller SG, et al: Thiazolidinediones repress ob gene expression in rodents via activation of peroxisome proliferator-activated receptor gamma. J Clin Invest 98:1004-1009, 1996
5. Kallen CB, Lazar MA: Antidiabetic thiazolidinediones inhibit leptin (ob) gene expression in 3T3-L1 adipocytes. Proc Natl Acad Sci USA 93:5793-5796, 1996
6. Anthony NH, Vedrana SS, John PM, et al: Functional antagonism between CCAAT/enhancer binding protein-α and peroxisome proliferator-activated receptor-γ on the leptin promoter. J Biol Chem 272:5283-5290, 1997
7. Nolan JJ, Olefsky JM, Nyce MR, et al: Effect of troglitazone on leptin production. Studies in vitro and in human subjects. Diabetes 45:1276-1278, 1996
8. Zhang B, Graziano MP, Doebber TW, et al: Down-regulation of the expression of the obese gene by an antidiabetic thiazolidinedione in Zucker diabetic fatty rats and db/db mice. J Biol Chem 271:9455-9459, 1996
9. Slieker LJ, Sloop KW, Surface PL, et al: Regulation of expression of ob mRNA and protein by glucocorticoids and cAMP. J Biol Chem 271:5301-5304, 1996
10. Kolaczynski JW, Nyce MR, Considine RV, et al: Acute and chronic effects of insulin on leptin production in humans: Studies in vivo and in vitro. Diabetes 45:699-701, 1996
11. Vidai H, Auboeuf D, DeVos P, et al: The expression of ob gene is not acutely regulated by insulin and fasting in human abdominal subcutaneous adipose tissue. J Clin Invest 98:251-255, 1996
12. Rentsch J, Chiesi M: Regulation of ob gene mRNA levels in cultured adipocytes. FEBS Lett 379:55-59, 1996
13. Boden G, Chen X, Kolaczynski JW, et al: Effects of prolonged hyperinsulinemia on serum leptin in normal human subjects. J Clin Invest 100:1107-1113, 1997
14. Hennes MM, Dua A, Maas DL, et al: Relationships of plasma leptin levels to changes in plasma free fatty acids in women who are lean and women who are abdominally obese. Obes Res 5:442-446, 1997
15. Peino R, Ferandez AJ, Penalva A, et al: Acute changes in free-fatty acids (FFA) do not alter serum leptin levels. J Endocrinol Invest 21:526-530, 1998
16. Tomoda H, Igarashi K, Omura S: Inhibition of acyl-CoA synthetase by triacsins. Biochim Biophys Acta 921:595-598, 1987
17. Nishimura H, Zarnowski MJ, Simpson IA: Glucose transporter recycling in rat adipose cells. Effects of potassium depletion. J Biol Chem 268:19246-19253, 1993
18. Hosoda K, Masuzaki H, Ogawa Y, et al: Development of radioimmunoassay for human leptin. Biochem Biophys Res Commun 221:234-239, 1996
19. Ogawa Y, Masuzaki H, Isse N. et al: Molecular cloning of rat obese cDNA and augmented gene expression in genetically obese Zucker fatty (fa/fa) rats. J Clin Invest 96:1647-1652, 1995
20. Satoh N, Ogawa Y, Katsuura G, et al: Pathophysiological significance of the obese gene product, leptin, in ventromedial hypothalamus (VMH)-lesioned rats: Evidence for loss of its satiety effect in VMH-lesioned rats. Endocrinology 138:947-954, 1997
21. Matsuoka N, Jingami H, Masuzaki H, et al: Effects of gemfibrozil administration on very low density lipoprotein receptor mRNA levels in rabbits. Atherosclerosis 126:221-226, 1996
22. Kawakami Y, Arai T, Okuda Y, et al: The regulation of obese (ob) gene expression by intracellular fatty acid concentration in adipocytes. Intern Med 38:213-215, 1999
23. Spiegelman BM, Hotamisligil GS: Through thick and thin: Wasting, obesity, and TNF alpha. Cell 73:625-627, 1993
24. Amri EZ, Bonino F, Ailhaud G, et al: Cloning of a protein that mediates transcriptional effects of fatty acids in preadipocytes. Homology to peroxisome proliferator-activated receptors. J Biol Chem 270:2367-2371, 1995
25. Mukherjee R, Jow L, Croston GE, et al: Identification, characterization, and tissue distribution of human peroxisome proliferator-activated receptor (PPAR) isoforms PPARgamma2 versus PPARgammal and activation with retinoid X receptor agonists and antagonists. J Biol Chem 272:8071-8076, 1997
26. Rotman BB, Papermaster BW: Membrane properties of living mammalian cells as studied by enzymatic hydrolysis of fluorogenic esters. Proc Natl Acad Sci USA 55:134-141, 1966
27. Macdougald OA, Hwang CS, Fan H, et al: Regulated expression of the obese product (leptin) in white adipose tissue and 3T3-L1 adipocytes. Proc Natl Acad Sci USA 92:9034-9037, 1995
28. Chavez RA, Moore HP: Targeting of leptin to the regulated secretory pathway in pituitary ArT-20 cells. Curr Biol 7:349-352, 1997
29. Bradley RL, Cheatham B: Regulation of ob gene expression and leptin secretion by insulin and dexamethasone in rat adipocytes. Diabetes 48:272-278, 1999
30. Cahill GF: Starvation in man. N Engl J Med 282:668-675, 1970
31. Kolaczynski JW, Considine RV, Ohannesian J, et al: Response of leptin to short-term fasting and refeeding in humans. Diabetes 45:1511-1515, 1997
32. Dubuc GR, Phiney SD, Stern JS, et al: Changes of serum leptin and endocrine and metabolic parameters after 7 days of energy restriction in men and women. Metabolism 47:429-434, 1998
33. Caro JF, Kolaczynski JW, Nyce MR, et al: Decreased cerebrospinal-fluid/serum leptin ratio in obesity: A possible mechanism for leptin resistance. Lancet 348:159-161, 1996
34. Bjorbaek C, Elmquist JK, Frantz JD, et al: Identification of SOCS-3 as a potential mediator of central leptin resistance. Mol Cell 1:619-625, 1998
35. Malmstrom R, Taskinen MR, Karonen SL, et al: Insulin increases plasma leptin concentrations in normal subjects and patients with NIDDM. Diabetologia 39:993-996, 1996